Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Turku University Hospital
Age
18–any
Sex
MALE
Healthy volunteers
Not accepted
You may be eligible if
Subjects must be able and willing to give written informed consent and to comply with the requirements of this study protocol
Subjects must be male, aged 18 years or above at Baseline
Histopathologically confirmed high risk (Gleason ≥4+4, PSA ≥20 and/ or cT≥3a) acinar or ductal adenocarcinoma of prostate
You may not be if
Allergy/sensitivity to study medications or their ingredients
Subjects unable to provide written informed consent
Subjects who have any other significant disease or disorder which, in the opinion of the investigator, may either put the subject at risk by participation in the study, or may influence the result of the study.
Subjects who have a history of drug or alcohol use that, in the opinion of the investigator, would interfere with adherence to study requirements.
Subjects who have androgen deprivation therapy initiated before enrolment
Subjects who have claustrophobia
Clareo Health | 99mTc-MIP-1404 SPECT/CT in Primary Staging of Prostate Cancer
